
|Articles|April 2, 2009
Supplements and Featured Publications
- Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular R
- Volume 15
- Issue 3
Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular Risk Beyond LDL Cholesterol in the Managed Care Setting
Advertisement
Articles in this issue
over 16 years ago
Introductionover 16 years ago
Participating Facultyover 16 years ago
The Impact of Residual CVD Risk in the Managed Care SettingNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5














































